Emmanuel S Antonarakis Selected Research

Hot Flashes

1/2018	A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer.
1/2013	Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emmanuel S Antonarakis Research Topics

Disease

295	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 11/2007
101	Neoplasms (Cancer) 05/2024 - 11/2004
40	Neoplasm Metastasis (Metastasis) 03/2024 - 09/2008
21	Circulating Neoplastic Cells 01/2024 - 01/2013
18	Disease Progression 03/2024 - 11/2010
10	Adenocarcinoma 01/2024 - 12/2012
6	Microsatellite Instability 01/2024 - 08/2017
4	Carcinogenesis 04/2024 - 10/2009
4	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2023 - 01/2019
4	Pain (Aches) 08/2021 - 10/2012
3	Diarrhea 01/2022 - 03/2011
3	Fatigue 01/2022 - 01/2013
3	Carcinoma (Carcinomatosis) 01/2020 - 04/2008
2	Turcot syndrome 01/2024 - 01/2020
2	Prostatic Intraepithelial Neoplasia 11/2023 - 03/2023
2	Margins of Excision 01/2023 - 01/2018
2	Genomic Instability 01/2021 - 10/2017
2	Chromosomal Instability (Chromosome Stability) 01/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 12/2019
2	Hypoxia (Hypoxemia) 01/2020 - 10/2019
2	Neutropenia 10/2019 - 03/2011
2	Febrile Neutropenia 01/2019 - 03/2011
2	Hypertension (High Blood Pressure) 01/2018 - 09/2011
2	Hot Flashes 01/2018 - 01/2013
2	Melanoma (Melanoma, Malignant) 05/2012 - 01/2012
1	Squamous Cell Carcinoma of Head and Neck 04/2024
1	Inflammation (Inflammations) 02/2024

Drug/Important Bio-Agent (IBA)

77	AndrogensIBA 05/2024 - 09/2008
63	Androgen Receptors (Androgen Receptor)IBA 03/2024 - 11/2011
55	enzalutamideIBA 03/2024 - 01/2013
47	abirateroneIBA 01/2024 - 08/2012
32	Hormones (Hormone)IBA 01/2024 - 11/2007
29	Docetaxel (Taxotere)FDA Link 11/2022 - 04/2008
28	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2009
25	Immune Checkpoint InhibitorsIBA 03/2024 - 05/2012
23	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2024 - 08/2017
22	Prostate-Specific Antigen (Semenogelase)IBA 03/2024 - 10/2009
20	AntigensIBA 01/2023 - 05/2010
18	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2010
16	Testosterone (Sustanon)FDA Link 01/2024 - 07/2013
15	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 01/2019
14	sipuleucel-T (APC8015)FDA Link 01/2023 - 05/2010
12	Messenger RNA (mRNA)IBA 05/2024 - 09/2014
12	taxaneIBA 01/2024 - 08/2015
12	VaccinesIBA 10/2021 - 02/2010
11	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2024 - 08/2017
10	pembrolizumabIBA 01/2024 - 01/2019
10	Abiraterone AcetateIBA 01/2023 - 01/2009
10	Radium-223IBA 01/2021 - 10/2012
9	Androgen Antagonists (Antiandrogens)IBA 03/2023 - 01/2016
8	olaparibIBA 01/2023 - 01/2018
7	RNA (Ribonucleic Acid)IBA 04/2024 - 09/2016
6	LigandsIBA 03/2024 - 01/2015
6	rucaparibIBA 10/2023 - 01/2020
6	Prednisone (Sone)FDA LinkGeneric 01/2023 - 05/2010
5	apalutamideIBA 03/2024 - 12/2016
5	Taxoids (Taxanes)IBA 01/2023 - 03/2011
5	prostatic acid phosphataseIBA 10/2021 - 05/2010
5	IpilimumabIBA 01/2021 - 01/2012
4	RadiopharmaceuticalsIBA 04/2023 - 10/2012
4	Circulating Tumor DNAIBA 01/2022 - 02/2014
4	Cell-Free Nucleic AcidsIBA 01/2022 - 11/2015
3	Programmed Cell Death 1 ReceptorIBA 03/2024 - 01/2018
3	darolutamideIBA 03/2024 - 01/2019
3	NivolumabIBA 01/2024 - 06/2018
3	B7-H1 AntigenIBA 01/2024 - 01/2018
3	Phenobarbital (Luminal)FDA Link 11/2023 - 01/2021
3	antiarrhythmic peptide (AAP)IBA 01/2023 - 07/2017
3	PlatinumIBA 12/2022 - 05/2010
3	AntibodiesIBA 10/2021 - 01/2018
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 02/2010
3	Androgen Receptor AntagonistsIBA 06/2019 - 12/2016
3	cabazitaxel FDA Link 10/2017 - 01/2011
2	Mitochondrial DNA (mtDNA)IBA 11/2023 - 03/2023
2	Histones (Histone)IBA 03/2023 - 12/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2022 - 09/2014
2	CytokinesIBA 12/2021 - 10/2015
2	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 12/2021 - 01/2020
2	EnzymesIBA 08/2021 - 01/2009
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 01/2018
2	bicalutamide (Casodex)FDA LinkGeneric 11/2020 - 01/2018
2	DNA VaccinesIBA 10/2020 - 05/2010
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 02/2010
2	A-Form DNA (A-DNA)IBA 12/2019 - 05/2012
2	3- hydroxy- 17- (1H- benzimidazole- 1- yl)androsta- 5,16- dieneIBA 12/2019 - 01/2016
2	Denosumab FDA Link 01/2019 - 01/2011
2	HhAntag691IBA 12/2016 - 09/2015
2	Formaldehyde (Formol)FDA Link 09/2016 - 10/2015
2	ParaffinIBA 09/2016 - 10/2015
2	Itraconazole (Sporanox)FDA LinkGeneric 04/2014 - 01/2013
2	Lenalidomide (CC 5013)FDA Link 04/2012 - 11/2010
1	tipifarnib (R115777)IBA 04/2024

Therapy/Procedure

182	Castration 05/2024 - 01/2009
155	Therapeutics 05/2024 - 11/2007
32	Immunotherapy 01/2024 - 02/2010
31	Drug Therapy (Chemotherapy) 01/2024 - 11/2004
21	Radiotherapy 01/2023 - 11/2007
16	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 11/2007
4	Aftercare (After-Treatment) 04/2024 - 07/2017
3	Precision Medicine 08/2021 - 08/2017